Semax 10mg

Semax 10mg is a synthetic heptapeptide research material intended for controlled laboratory, analytical, and scientific investigation. Semax is studied in experimental settings involving peptide characterization, molecular signaling, enzyme interactions, and neurobiological research models.

Supplied by Peptides R US strictly for research use only.

Not for human or veterinary use. Not intended for consumption, administration, diagnosis, treatment, prevention, or clinical use.

Detailed Description

Semax 10mg Research Peptide

Semax 10mg is a synthetic heptapeptide intended exclusively for laboratory, analytical, and scientific research.

FDA materials describe Semax as a synthetic heptapeptide analogue related to the ACTH₄–₁₀ fragment. Its commonly referenced amino-acid sequence is Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP).

Semax may be investigated in controlled research environments involving:

• Peptide identity and characterization
• Neurobiological research models
• Peptide–enzyme interaction studies
• Molecular signaling research
• Biochemical pathway investigation
• Analytical method development
• Peptide stability studies
• Structure–activity research
• In-vitro experimental models
• Comparative peptide analysis

Published and regulatory discussions have examined Semax in various preclinical neurological research models. Such experimental findings should not be interpreted as established safety, effectiveness, or therapeutic benefit in humans.

Product Information

• Product: Semax
• Strength: 10mg
• Classification: Synthetic heptapeptide
• Sequence: Met-Glu-His-Phe-Pro-Gly-Pro
• Abbreviated Sequence: MEHFPGP
• Primary Research Area: Neurobiological research
• Intended Setting: Laboratory, analytical, and scientific research
• Supplier: Peptides R US

Regulatory / Research Use Notice

This product is offered solely for legitimate laboratory, analytical, and scientific research purposes.

It is not intended for human or veterinary consumption or administration and is not intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition.

No dosage, intranasal-use, injection, reconstitution-for-human-use, therapeutic, or clinical-use instructions are provided or implied.

FDA states that neither Semax free base nor Semax acetate is a component of an FDA-approved drug, and FDA’s 2026 evaluation concluded that the applicable criteria weighed against adding those substances to the 503A Bulks List. FDA also identifies potential concerns involving immunogenicity, aggregation, and peptide-related impurities for compounded Semax products.